BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report-Reference-Cited by-同舟云学术

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection: A Preliminary Report

Published:2021-05-19 Issue: Volume: Page:
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Bianchi Francesco Paolo¹,Germinario Cinzia Annatea¹,Migliore Giovanni²,Vimercati Luigi³,Martinelli Andrea¹,Lobifaro Annamaria¹,Tafuri Silvio¹,Stefanizzi Pasquale¹,Amoruso Fabio,Capodiferro Luca,De Crescenzio Irene,Furio Alessandro,Lattanzio Sabrina,Nozza Mirella,Parnoffi Nicole,Rella Michela,Riformato Giacomo,Spinelli Giuseppe,Manicone Annalucia,

Affiliation:

1. Department of Biomedical Science and Human Oncology, Aldo Moro University of Bari, Bari, Italy

2. Bari Policlinico General Hospital, Bari, Italy

3. Department of Interdisciplinary Medicine, Aldo Moro University of Bari, Bari, Italy

Abstract

Abstract In the preregistration trial, data on efficacy of BNT162b2 mRNA vaccine against SARS-CoV-2 infection were not collected. This study aimed to evaluate vaccine effectiveness (VE) against documented infection. Bari Policlinico University Hospital health care workers (HCWs) who completed the vaccination schedule were matched with HCWs who had refused vaccination. VE for documented infection was 61.9% (95% confidence interval [CI], 19.2%–82.0%) 14–20 days after first dose, 87.9% (95% CI, 51.7%–97.0%) 21–27 days after first dose, and 96.0% (95% CI, 82.2%–99.1%) 7 or more days after second dose. Unvaccinated HCWs remain a concern in the context of the pandemic emergency.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/advance-article-pdf/doi/10.1093/infdis/jiab262/38814214/jiab262.pdf

Reference15 articles.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consequences of COVID-19 Vaccine Hesitancy Among Healthcare Providers During the First 10 Months of Vaccine Availability: Scoping Review;Canadian Journal of Nursing Research;2024-05-02

2. Vaccine efficacy against SARS-CoV-2 for Pfizer BioNTech, Moderna, and AstraZeneca vaccines: a systematic review;Frontiers in Public Health;2023-10-24

3. Attitudes toward influenza vaccination in healthcare workers in Italy: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2023-10-17

4. Effectiveness of mRNA and viral‐vector vaccines in epidemic period led by different SARS‐CoV‐2 variants: A systematic review and meta‐analysis;Journal of Medical Virology;2023-03

5. Signs and symptoms commonly seen in COVID-19 in newborns, children, and adolescents and pediatric subjects;Clinical Management of Pediatric COVID-19;2023